ALHC Quote, Financials, Valuation and Earnings

Centene has a net margin of -4.43% compared to Alignment Healthcare's net margin of 0.69%. Alignment Healthcare's return on equity of -101.38% beat Centene's return on equity of 12.3%.

Alignment Healthcare has a consensus price target of $17.32, signalling downside risk potential of -4.37%. On the other hand Centene has an analysts' consensus of $78.62 which suggests that it could grow by 26.96%. Given that Centene has higher upside potential than Alignment Healthcare, analysts believe Centene is more attractive than Alignment Healthcare.

Alignment Healthcare has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Centene has a beta of 0.529, suggesting its less volatile than the S&P 500 by 47.066%.

Alignment Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Centene offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alignment Healthcare pays -- of its earnings as a dividend. Centene pays out -- of its earnings as a dividend.

Alignment Healthcare quarterly revenues are $701.2M, which are smaller than Centene quarterly revenues of $40.8B. Alignment Healthcare's net income of -$31.1M is lower than Centene's net income of $283M. Notably, Alignment Healthcare's price-to-earnings ratio is -- while Centene's PE ratio is 9.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alignment Healthcare is 1.28x versus 0.20x for Centene. Usually stocks with elevated PS ratios are considered overvalued.

Molina Healthcare has a net margin of -4.43% compared to Alignment Healthcare's net margin of 2.39%. Alignment Healthcare's return on equity of -101.38% beat Molina Healthcare's return on equity of 25.84%.

Alignment Healthcare has a consensus price target of $17.32, signalling downside risk potential of -4.37%. On the other hand Molina Healthcare has an analysts' consensus of $338.46 which suggests that it could fall by -2.38%. Given that Alignment Healthcare has more downside risk than Molina Healthcare, analysts believe Molina Healthcare is more attractive than Alignment Healthcare.

Alignment Healthcare has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Molina Healthcare has a beta of 0.701, suggesting its less volatile than the S&P 500 by 29.866%.

Alignment Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Molina Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alignment Healthcare pays -- of its earnings as a dividend. Molina Healthcare pays out -- of its earnings as a dividend.

Alignment Healthcare quarterly revenues are $701.2M, which are smaller than Molina Healthcare quarterly revenues of $10.5B. Alignment Healthcare's net income of -$31.1M is lower than Molina Healthcare's net income of $251M. Notably, Alignment Healthcare's price-to-earnings ratio is -- while Molina Healthcare's PE ratio is 16.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alignment Healthcare is 1.28x versus 0.49x for Molina Healthcare. Usually stocks with elevated PS ratios are considered overvalued.

Progyny has a net margin of -4.43% compared to Alignment Healthcare's net margin of 3.53%. Alignment Healthcare's return on equity of -101.38% beat Progyny's return on equity of 11.14%.

Alignment Healthcare has a consensus price target of $17.32, signalling downside risk potential of -4.37%. On the other hand Progyny has an analysts' consensus of $26.75 which suggests that it could grow by 18.36%. Given that Progyny has higher upside potential than Alignment Healthcare, analysts believe Progyny is more attractive than Alignment Healthcare.

Alignment Healthcare has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Progyny has a beta of 1.328, suggesting its more volatile than the S&P 500 by 32.843%.

Alignment Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Progyny offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Alignment Healthcare pays -- of its earnings as a dividend. Progyny pays out -- of its earnings as a dividend.

Alignment Healthcare quarterly revenues are $701.2M, which are larger than Progyny quarterly revenues of $298.4M. Alignment Healthcare's net income of -$31.1M is lower than Progyny's net income of $10.5M. Notably, Alignment Healthcare's price-to-earnings ratio is -- while Progyny's PE ratio is 39.65x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alignment Healthcare is 1.28x versus 1.87x for Progyny. Usually stocks with elevated PS ratios are considered overvalued.

UnitedHealth Group has a net margin of -4.43% compared to Alignment Healthcare's net margin of 5.5%. Alignment Healthcare's return on equity of -101.38% beat UnitedHealth Group's return on equity of 14.34%.

Alignment Healthcare has a consensus price target of $17.32, signalling downside risk potential of -4.37%. On the other hand UnitedHealth Group has an analysts' consensus of $628.30 which suggests that it could grow by 19.67%. Given that UnitedHealth Group has higher upside potential than Alignment Healthcare, analysts believe UnitedHealth Group is more attractive than Alignment Healthcare.

Alignment Healthcare has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison UnitedHealth Group has a beta of 0.607, suggesting its less volatile than the S&P 500 by 39.293%.

Alignment Healthcare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UnitedHealth Group offers a yield of 1.6% to investors and pays a quarterly dividend of $2.10 per share. Alignment Healthcare pays -- of its earnings as a dividend. UnitedHealth Group pays out 52.29% of its earnings as a dividend. UnitedHealth Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Alignment Healthcare quarterly revenues are $701.2M, which are smaller than UnitedHealth Group quarterly revenues of $100.8B. Alignment Healthcare's net income of -$31.1M is lower than UnitedHealth Group's net income of $5.5B. Notably, Alignment Healthcare's price-to-earnings ratio is -- while UnitedHealth Group's PE ratio is 33.87x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Alignment Healthcare is 1.28x versus 1.22x for UnitedHealth Group. Usually stocks with elevated PS ratios are considered overvalued.